<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>health informatics</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>health informatics | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Improving epileptogenic zone estimation using Bayesian inference on neural field models
Authors: Vattikonda, A. N.; Woodman, M. M.; Lemarechal, J.-D.; Daini, D.; Hashemi, M.; Bartolomei, F.; Jirsa, V.
Score: 4.0, Published: 2023-10-03 DOI: 10.1101/2023.10.01.23296377
Epilepsy remains a significant medical challenge, particularly in drug-resistant cases where surgical intervention may be the only viable treatment option. Identifying the epileptogenic zone, the brain region responsible for seizure initiation, is a critical step in surgical planning.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/health-informatics/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="health informatics" />
<meta property="og:description" content="Improving epileptogenic zone estimation using Bayesian inference on neural field models
Authors: Vattikonda, A. N.; Woodman, M. M.; Lemarechal, J.-D.; Daini, D.; Hashemi, M.; Bartolomei, F.; Jirsa, V.
Score: 4.0, Published: 2023-10-03 DOI: 10.1101/2023.10.01.23296377
Epilepsy remains a significant medical challenge, particularly in drug-resistant cases where surgical intervention may be the only viable treatment option. Identifying the epileptogenic zone, the brain region responsible for seizure initiation, is a critical step in surgical planning." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/health-informatics/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-10-25T10:39:04+00:00" />
<meta property="article:modified_time" content="2023-10-25T10:39:04+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="health informatics"/>
<meta name="twitter:description" content="Improving epileptogenic zone estimation using Bayesian inference on neural field models
Authors: Vattikonda, A. N.; Woodman, M. M.; Lemarechal, J.-D.; Daini, D.; Hashemi, M.; Bartolomei, F.; Jirsa, V.
Score: 4.0, Published: 2023-10-03 DOI: 10.1101/2023.10.01.23296377
Epilepsy remains a significant medical challenge, particularly in drug-resistant cases where surgical intervention may be the only viable treatment option. Identifying the epileptogenic zone, the brain region responsible for seizure initiation, is a critical step in surgical planning."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "health informatics",
      "item": "https://trxiv.yorks0n.com/posts/health-informatics/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "health informatics",
  "name": "health informatics",
  "description": "Improving epileptogenic zone estimation using Bayesian inference on neural field models\nAuthors: Vattikonda, A. N.; Woodman, M. M.; Lemarechal, J.-D.; Daini, D.; Hashemi, M.; Bartolomei, F.; Jirsa, V.\nScore: 4.0, Published: 2023-10-03 DOI: 10.1101/2023.10.01.23296377\nEpilepsy remains a significant medical challenge, particularly in drug-resistant cases where surgical intervention may be the only viable treatment option. Identifying the epileptogenic zone, the brain region responsible for seizure initiation, is a critical step in surgical planning.",
  "keywords": [
    
  ],
  "articleBody": " Improving epileptogenic zone estimation using Bayesian inference on neural field models\nAuthors: Vattikonda, A. N.; Woodman, M. M.; Lemarechal, J.-D.; Daini, D.; Hashemi, M.; Bartolomei, F.; Jirsa, V.\nScore: 4.0, Published: 2023-10-03 DOI: 10.1101/2023.10.01.23296377\nEpilepsy remains a significant medical challenge, particularly in drug-resistant cases where surgical intervention may be the only viable treatment option. Identifying the epileptogenic zone, the brain region responsible for seizure initiation, is a critical step in surgical planning. Combining dynamical system models and the neuroimaging data of epileptic patients in a Bayesian framework has previously been shown to be a promising approach to identify the epileptogenic zone. However, previous studies employed coupled neural mass models to describe the whole brain seizure dynamics and hence could only provide a highly coarse spatially estimate of the epileptogenic zone. In this study we propose an extension of the Bayesian virtual epileptic patient framework to a neural field model which could improve the spatial resolution by several orders. Performing model inversion using neural field models is a challenging task since: (i) it is computationally expensive to compute gradients over a neural field simulation and (ii) parameter space can be very high dimensional. We demonstrate that using pseudo-spectral methods and spherical harmonic transforms it is feasible to perform Bayesian model inversion on a neural field extension of the reduced Epileptor model. We found that the neural field extension not only improves the spatial resolution but also significantly reduces the number of false positives.\nDiabetIA: Building Machine Learning Models for Type 2 Diabetes Complications\nAuthors: Tripp, J.; Santana-Quinteros, D.; Perez-Estrada, R.; Rodriguez-Moran, M. F.; Arcos-Gonzalez, C.; Mercado-Rios, J.; Cristobal-Perez, F.; Hernandez-Martinez, B. R.; Nava-Aguilar, M. A.; Gonzalez-Arroyo, G.; Salazar-Fernandez, E. P.; Quiroz-Armada, P. S.; Cortes-Vieyra, R.; Noriega-Cisneros, R.; Zinzun-Ixta, G.; Maldonado-Pichardo, M. C.; Flores-Alvarez, L. J.; Reyes-Granados, S. C.; Chagolla-Morales, R.; Paredes-Saralegui, J. G.; Flores-Garrido, M.; Garcia-Velazquez, L. M.; Figueroa-Mora, K. M.; Gomez-Garcia, A.; Alvarez-Aguilar, C.; Lopez-Pineda, A.\nScore: 3.0, Published: 2023-10-23 DOI: 10.1101/2023.10.22.23297277\nBackground: Artificial intelligence (AI) models applied to diabetes mellitus research have grown in recent years, particularly in the field of medical imaging. However little work has been done with exploring real-world data (RWD) sources such as electronic health records (EHR) mostly due to the lack of reliable public diabetes databases. However, with more than 500 million patients affected worldwide, complications of this condition have catastrophic consequences. In this manuscript we aim to first extract, clean and transform a novel diabetes research database, DiabetIA, and secondly train machine learning (ML) models to predict diabetic complications. Methods: In this study, we used observational retrospective data from the Mexican Institute for Social Security (IMSS) extracting and de-identifying EHR data for almost 2 million patients seen at primary care facilities. After applying eligibility criteria for this study, we constructed a diabetes complications database. Next, we trained naive Bayesian models with various subsets of variables, including an expert-selected model. Results: The DiabetIA database is composed of 136,674 patients (414,770 records and 447 variables), with 33,314 presenting diabetes (24.3%). The most frequent diabetic complications were diabetic foot with 2,537 patients, nephropathy with 1,914 patients, retinopathy with 1,829 patients, and neuropathy with 786 patients. These complications were accurately predicted by the Gaussian naive Bayessian models with an average area under the curve AUC of 0.86. Our expert-selected model, achieved an average AUC of 0.84 with 21 curated variables. Conclusion: Our study offers the largest longitudinal research database from EHR data in Latin America for research. The DiabetIA database provides a useful resource to estimate the burden of diabetic complications on healthcare systems. Machine learning models can provide accurate estimations of the total cases presented in medical units. For patients and their clinicians, it is imperative to have a way to calculate this risk and start clinical interventions to slow down or prevent the complications of this condition.\nFDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An updated landscape\nAuthors: Joshi, G.; Jain, A.; Araveeti, S. R.; Adhikari, S.; Garg, H.; Bhandari, M.\nScore: 3.0, Published: 2023-10-23 DOI: 10.1101/2022.12.07.22283216\nAs artificial intelligence (AI) has been highly advancing in the last decade, machine learning (ML) enabled medical devices are increasingly used in healthcare. In this article, we performed comprehensive analysis of FDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices and offer an in-depth analysis of clearance pathways, approval timeline, regulation type, medical specialty, decision type, recall history etc. We found a significant surge in approvals since 2018, with clear dominance of radiology specialty in the application of machine learning tools, attributed to the abundant data from routine clinical data. The study also reveals a reliance on the 510(k)-clearance pathway, emphasizing its basis on substantial equivalence and often bypassing the need for new clinical trials. Also, it notes an underrepresentation of pediatric-focused devices and trials, suggesting an opportunity for expansion in this demographic. Moreover, the geographical limitation of clinical trials, primarily within the United States, points to a need for more globally inclusive trails to encompass diverse patient demographics. This analysis not only maps the current landscape of AI/ML-Enabled Medical Devices but also pinpoints trends, potential gaps, and areas for future exploration, clinical trial practices, and regulatory approaches.\n",
  "wordCount" : "854",
  "inLanguage": "en",
  "datePublished": "2023-10-25T10:39:04Z",
  "dateModified": "2023-10-25T10:39:04Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/health-informatics/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      health informatics
    </h1>
    <div class="post-meta"><span>updated on October 25, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.01.23296377">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.01.23296377" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.01.23296377">
        <p class="paperTitle">Improving epileptogenic zone estimation using Bayesian inference on neural field models</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.01.23296377" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.01.23296377" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Vattikonda, A. N.; Woodman, M. M.; Lemarechal, J.-D.; Daini, D.; Hashemi, M.; Bartolomei, F.; Jirsa, V.</p>
        <p class="info">Score: 4.0, Published: 2023-10-03 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.01.23296377' target='https://doi.org/10.1101/2023.10.01.23296377'> 10.1101/2023.10.01.23296377</a></p>
        <p class="abstract">Epilepsy remains a significant medical challenge, particularly in drug-resistant cases where surgical intervention may be the only viable treatment option. Identifying the epileptogenic zone, the brain region responsible for seizure initiation, is a critical step in surgical planning. Combining dynamical system models and the neuroimaging data of epileptic patients in a Bayesian framework has previously been shown to be a promising approach to identify the epileptogenic zone. However, previous studies employed coupled neural mass models to describe the whole brain seizure dynamics and hence could only provide a highly coarse spatially estimate of the epileptogenic zone. In this study we propose an extension of the Bayesian virtual epileptic patient framework to a neural field model which could improve the spatial resolution by several orders. Performing model inversion using neural field models is a challenging task since: (i) it is computationally expensive to compute gradients over a neural field simulation and (ii) parameter space can be very high dimensional. We demonstrate that using pseudo-spectral methods and spherical harmonic transforms it is feasible to perform Bayesian model inversion on a neural field extension of the reduced Epileptor model. We found that the neural field extension not only improves the spatial resolution but also significantly reduces the number of false positives.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.22.23297277">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.22.23297277" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.22.23297277">
        <p class="paperTitle">DiabetIA: Building Machine Learning Models for Type 2 Diabetes Complications</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.22.23297277" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.22.23297277" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Tripp, J.; Santana-Quinteros, D.; Perez-Estrada, R.; Rodriguez-Moran, M. F.; Arcos-Gonzalez, C.; Mercado-Rios, J.; Cristobal-Perez, F.; Hernandez-Martinez, B. R.; Nava-Aguilar, M. A.; Gonzalez-Arroyo, G.; Salazar-Fernandez, E. P.; Quiroz-Armada, P. S.; Cortes-Vieyra, R.; Noriega-Cisneros, R.; Zinzun-Ixta, G.; Maldonado-Pichardo, M. C.; Flores-Alvarez, L. J.; Reyes-Granados, S. C.; Chagolla-Morales, R.; Paredes-Saralegui, J. G.; Flores-Garrido, M.; Garcia-Velazquez, L. M.; Figueroa-Mora, K. M.; Gomez-Garcia, A.; Alvarez-Aguilar, C.; Lopez-Pineda, A.</p>
        <p class="info">Score: 3.0, Published: 2023-10-23 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.22.23297277' target='https://doi.org/10.1101/2023.10.22.23297277'> 10.1101/2023.10.22.23297277</a></p>
        <p class="abstract">Background: Artificial intelligence (AI) models applied to diabetes mellitus research have grown in recent years, particularly in the field of medical imaging. However little work has been done with exploring real-world data (RWD) sources such as electronic health records (EHR) mostly due to the lack of reliable public diabetes databases. However, with more than 500 million patients affected worldwide, complications of this condition have catastrophic consequences. In this manuscript we aim to first extract, clean and transform a novel diabetes research database, DiabetIA, and secondly train machine learning (ML) models to predict diabetic complications. Methods: In this study, we used observational retrospective data from the Mexican Institute for Social Security (IMSS) extracting and de-identifying EHR data for almost 2 million patients seen at primary care facilities. After applying eligibility criteria for this study, we constructed a diabetes complications database. Next, we trained naive Bayesian models with various subsets of variables, including an expert-selected model. Results: The DiabetIA database is composed of 136,674 patients (414,770 records and 447 variables), with 33,314 presenting diabetes (24.3%). The most frequent diabetic complications were diabetic foot with 2,537 patients, nephropathy with 1,914 patients, retinopathy with 1,829 patients, and neuropathy with 786 patients. These complications were accurately predicted by the Gaussian naive Bayessian models with an average area under the curve AUC of 0.86. Our expert-selected model, achieved an average AUC of 0.84 with 21 curated variables. Conclusion: Our study offers the largest longitudinal research database from EHR data in Latin America for research. The DiabetIA database provides a useful resource to estimate the burden of diabetic complications on healthcare systems. Machine learning models can provide accurate estimations of the total cases presented in medical units. For patients and their clinicians, it is imperative to have a way to calculate this risk and start clinical interventions to slow down or prevent the complications of this condition.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2022.12.07.22283216">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2022.12.07.22283216" aria-expanded="false" aria-controls="flush-collapse10.1101/2022.12.07.22283216">
        <p class="paperTitle">FDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An updated landscape</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2022.12.07.22283216" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2022.12.07.22283216" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Joshi, G.; Jain, A.; Araveeti, S. R.; Adhikari, S.; Garg, H.; Bhandari, M.</p>
        <p class="info">Score: 3.0, Published: 2023-10-23 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2022.12.07.22283216' target='https://doi.org/10.1101/2022.12.07.22283216'> 10.1101/2022.12.07.22283216</a></p>
        <p class="abstract">As artificial intelligence (AI) has been highly advancing in the last decade, machine learning (ML) enabled medical devices are increasingly used in healthcare. In this article, we performed comprehensive analysis of FDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices and offer an in-depth analysis of clearance pathways, approval timeline, regulation type, medical specialty, decision type, recall history etc. We found a significant surge in approvals since 2018, with clear dominance of radiology specialty in the application of machine learning tools, attributed to the abundant data from routine clinical data. The study also reveals a reliance on the 510(k)-clearance pathway, emphasizing its basis on substantial equivalence and often bypassing the need for new clinical trials. Also, it notes an underrepresentation of pediatric-focused devices and trials, suggesting an opportunity for expansion in this demographic. Moreover, the geographical limitation of clinical trials, primarily within the United States, points to a need for more globally inclusive trails to encompass diverse patient demographics. This analysis not only maps the current landscape of AI/ML-Enabled Medical Devices but also pinpoints trends, potential gaps, and areas for future exploration, clinical trial practices, and regulatory approaches.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
